Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

VEGFR

Items 11-20 of 54

Page
per page
  1. Dovitinib (TKI258) Lactate
    B5953 Dovitinib (TKI258) Lactate
    Target: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFR
    Summary: Oral tyrosine kinase inhibitor (TKI) against FGFR1–3, VEGFR1–3, and platelet-derived growth factor receptor (PDGFR).
      insoluble in EtOH; ≥10.62 mg/mL
  2. Fruquintinib(HMPL-013)
    B5864 Fruquintinib(HMPL-013)
    Target: VEGFR
    Summary: Potent and selective inhibitor of VEGFR 1, 2, 3
      insoluble in H2O; insoluble in EtOH; ≥6.35 mg/mL
  3. AZD2932
    B5835 AZD2932
    Target: FLT3|VEGFR|PDGFR|c-Kit
    Summary: inhibitor of VEGFR-2, PDGFRβ, Flt-3, and c-Kit
      Soluble in DMSO
  4. DMH4
    B5611 DMH4
     1 Citation
    Summary: VEGFR-2 inhibitor
      <20.02 mg/mL
  5. (Z)-FeCP-oxindole
    B5491 (Z)-FeCP-oxindole
    Summary: VEGFR-2 inhibitor
      insoluble in DMSO
  6. (E)-FeCP-oxindole
    B5490 (E)-FeCP-oxindole
    Summary: VEGFR-2 inhibitor
      insoluble in DMSO
  7. EG00229
    B4657 EG00229
    Summary: Nrp1 inhibitor
      ≥26.25 mg/mL
  8. Apatinib
    B2303 Apatinib
     4 Citation
    Summary: VEGFR2 inhibitor, orally bioavailable, selective
      ≥49.4 mg/mL
  9. SAR131675
    B2301 SAR131675
    Summary: VEGFR3 inhibitor,selective and ATP-competitve
      insoluble in DMSO; insoluble in EtOH; insoluble in H2O
  10. CP-673451
    B2173 CP-673451
    Target: PDGFR
    Summary: PDGFRα/β inhibitor,potent and selective

Items 11-20 of 54

Page
per page